[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ascending-aorta-abnormality\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ascending-aorta-abnormality":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":27,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100420397","valved-graft-pmcf-study-100420397",false,"NCT04754217","Valved Graft PMCF Study","Valved Graft Post-Market Clinical Follow-up Study","Inclusion Criteria:\n\n* cardiac surgery including the implant of a VAVGJ or CAVGJ for native or prosthetic valve replacement\n\nExclusion Criteria:\n\n* anticoagulation therapy intolerant\n* active endocarditis\n* anatomical or medical, surgical, psychological or social contraindications","ALL","18 Years",{"count":19,"type":20},260,"ESTIMATED","OBSERVATIONAL","Multicenter, global, prospective, non-randomized, interventional, post-market trial. All subjects enrolled will receive an Abbott Valved Graft device.",[24,25,26],"Aortic Valve Disease","Ascending Aorta Abnormality","Aortic Dissection",[28,29,30,31,32],"Aortic Root Replacement","Ascending Aorta Replacement","Valved Graft","CAVGJ","VAVGJ","RECRUITING","2026-04-07",{"date":36,"type":37},"2026-04-13","ACTUAL",{"date":39,"type":37},"2021-07-13",{"date":41,"type":20},"2029-09",{"name":43,"class":44},"Abbott Medical Devices","INDUSTRY",25]